Pharmafile Logo
Pharmafocus logo
Advanced Search

spirogen

Showing 1 posts of 1 posts found.

astrazeneca image

AstraZeneca pays $460m for cancer specialists

October 15, 2013
Research and Development, Sales and Marketing ADC, AstraZeneca, Cancer, MedImmune, spirogen

AstraZeneca’s biologics arm MedImmune has bought cancer biotech firm Spirogen and set up a licensing deal with ADC Therapeutics for …

News
The Gateway to Local Adoption Series

Latest content

Dermatology leader Doncker is new Onicor CEO

October 29, 2026

East London pharmacies pilot cholesterol-lowering injections to cut waiting times

October 29, 2026

Weber is new CMO at Sensorion

October 28, 2026

Charity commits £800,000 to AI research into late breast cancer recurrence

October 28, 2026

AstraZeneca’s Trixeo approved in EU for asthma in patients aged 12 and over

October 27, 2026